Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis. (2021)

First Author: Furlong-Silva J
Attributed to:  Is targeting vascular remodelling by filarial parasites a viable anti-morbidity solution? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci140853

PubMed Identifier: 33434186

Publication URI: http://europepmc.org/abstract/MED/33434186

Type: Journal Article/Review

Volume: 131

Parent Publication: The Journal of clinical investigation

Issue: 5

ISSN: 0021-9738